TARS | NASDAQ
$78.61
$1.92 | 2.50%
SIGNAL:
|2026-09-30
|F&G 59
|RSI 55.9
|2026-09-30
|F&G 59
|RSI 55.9
Company Overview:
Market Cap:
$3.68B
Trailing PE:
N/A
FWD PE:
—
Payout Ratio (TTM):
—
52-Week Range:
$53.89 - $91.53
6 Year TARS Performance Metrics:
Total Return (with DRIP):
282.0% (25.03% CAGR)
Total Return (no DRIP):
282.0% (25.03% CAGR)
Share Price:
282.0% (25.03% CAGR)
Yield on Cost (with DRIP):
—
Total Invested:
$10,000
Total Value (with DRIP):
$38,197
Total Return $ (with DRIP):
$28,197
TARS Total Return
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
TARS Price Chart
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
All
Unlock All Reports & Research Dividend Stocks like a BOSS!
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
TARS Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
TARS Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Gross Profit CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Shares Outstanding CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
TARS Actual Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Ratios, Profit Margins & Return on Capital:
TARS Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Gross Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Price To Sales Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TARS Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Projected Future Returns & Dividends for TARS
Based on past 6-year performance, here are TARS growth metrics:
Share price CAGR of +25.03%
Dividend CAGR of +0%
Using TARS CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| TARS (DRIP) | TARS - No DRIP | |
|---|---|---|
| Current Price | $78.61 | $78.61 |
| Start Shares | 127.21 | 127.21 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 127.21 | 127.21 |
| Dividends Payment | $0.00 | $0.00 |
| Annual Dividends | $0 | $0 |
| Yield on cost | 0.00% | 0.00% |
| Share Price | $78.61 | $78.61 |
| Total Dividends | $0 | $0 |
| Final Value | $10,000 | $10,000 |
Estimated Future Value + Dividends - TARS
NOTE: Above numbers are our estimate based on TARS's Dividend and Price CAGR over past 6 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
Company Info
Tarsus Pharmaceuticals Inc. (TARS) had its IPO on , and is traded on NASDAQ stock exchange.
Tarsus Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on eye care. The company develops and commercializes therapies for diseases of the ocular surface, with its lead product addressing demodex blepharitis, a common eyelid condition caused by Demodex mites. Tarsus Pharmaceuticals also advances additional ophthalmology assets and supports a broader eye-care franchise aimed at treating unmet needs in outpatient and specialist settings. Its business combines drug development, regulatory execution, and commercial distribution, making it an important participant in the ophthalmology and specialty pharmaceuticals market. Headquartered in Irvine, California, Tarsus Pharmaceuticals Inc. concentrates on transforming proven science into targeted treatments for patients and eye-care providers.
TARS website: https://tarsusrx.com
Get Full Access to All Reports with DRIPCalc PRO
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
Loading signals…
DCF Model — TARS
Value from:
🔒 Upgrade to unlock
The full DCF valuation — fair value, implied growth and the price path — is a paid feature.
Upgrade
Pay up to today
—
vs current price $78.61
—
Cash flow & implied price by year
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
| Year | FCF | Implied price |
|---|
Sensitivity — fair value: growth ↓ × target return →
